dbacp05076
General Description
Peptide name : P5
Source/Organism : Ceropin A-African clawed frog
Linear/Cyclic : Linear
Chirality : L
Sequence Information
Sequence : KWKLFKKIGIGAFLHLAKKF
Peptide length: 20
C-terminal modification: Linear
N-terminal modification : Amidation
Non-natural peptide information: None
Activity Information
Assay type : MTT/MTS assay
Assay time : 72h
Activity : IC50 : 2.9 µM
Cell line : NCI-H128
Cancer type : Lung cancer
Other activity : Hemolytic activity
Physicochemical Properties
Amino acid composition bar chart :
Molecular mass : 2373.9661 Dalton
Aliphatic index : 1.075
Instability index : -14.995
Hydrophobicity (GRAVY) : 0.205
Isoelectric point : 10.699
Charge (pH 7) : 5.8413
Aromaticity : 0.2
Molar extinction coefficient (cysteine, cystine): (5500, 5500)
Hydrophobic/hydrophilic ratio : 1.85714285
hydrophobic moment : -0.003
Missing amino acid : C,R,Q,T,P,M,E,S,D,Y,N,V
Most occurring amino acid : K
Most occurring amino acid frequency : 6
Least occurring amino acid : W
Least occurring amino acid frequency : 1
Structural Information
3D structure :
Secondary structure fraction (Helix, Turn, Sheet): (0.5, 0.1, 0.4)
SMILES Notation: CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CCCCN)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O
Secondary Structure :
| Method | Prediction |
|---|---|
| GOR | HHHHHHHHHHHHHHHHHHHH |
| Chou-Fasman (CF) | HHHHHHEEEEHHHHHHHCCC |
| Neural Network (NN) | HHHHHHHCCHHHHHHHHHHH |
| Joint/Consensus | HHHHHHHCCHHHHHHHHHHH |
Molecular Descriptors and ADMET Properties
Molecular Descriptors: Click here to download
ADMET Properties: Click here to download
Cross Referencing databases
Reference
1 : Shin SY, et al. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. J Pept Res. 1997; 50:279-85. doi: 10.1111/j.1399-3011.1997.tb01469.x
Literature
Paper title : Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Doi : https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
Abstract : The hybrid peptide (CA-ME) derived from cecropin A(1-8) and melittin (1-12) has potent antibacterial and antimalarial activities. Because the N-terminal sequence 1-12 of magainin 2 is similar to melittin(1-12), CA-MA with CA(1-8) and MA(1-12) and their analogues were designed and synthesized. Antitumor activities of these peptides were evaluated using three small cell lung cancer cell lines. Greater antitumor activity was observed when the residues 16, 18 and 19 of the peptide were hydrophobic (Leu or Val), basic (Lys) and basic (Lys), respectively. The IC50 values of the peptides with the residues were 2 to 4 microM. Residue 12 was related to hemolytic activity rather than antitumor activity. Increase in amphipathicity of P4 enhanced hemolytic activity without significant change in antitumor activity. The alpha-helicity of the peptides in a 30 mM sodium dodecyl sulfate solution was more closely correlated to hemolytic activity than antitumor activity.